Drug Shortage Report for PRIVA-CETIRIZINE

Last updated on 2020-03-12 History
Report ID 104941
Drug Identification Number 02427192
Brand name PRIVA-CETIRIZINE
Common or Proper name CETIRIZINE
Company Name PHARMAPAR INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) CETIRIZINE HYDROCHLORIDE
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code R06AE
ATC description ANTIHISTAMINES FOR SYSTEMIC USE
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-01-30
Estimated end date 2020-03-16
Actual end date 2020-03-11
Shortage status Resolved
Updated date 2020-03-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1565 BOUL LIONEL-BOULET
VARENNES, QUEBEC
CANADA J3X 1P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-03-12 English Compare
v9 2020-03-11 French Compare
v8 2020-03-11 English Compare
v7 2020-03-04 French Compare
v6 2020-03-04 English Compare
v5 2020-02-14 French Compare
v4 2020-02-14 English Compare
v3 2020-01-31 English Compare
v2 2020-01-30 French Compare
v1 2020-01-30 English Compare

Showing 1 to 10 of 10